CRISPR-Cas9 harnessed for genome editing
January, 2013 — Feng Zhang, Broad Institute of MIT and Harvard, McGovern Institute for Brain Research at MIT, Massachusetts
After almost two decades of development this powerful system of gene editing has become commercially viable opening doors to advances and controversies
Illustration by Stephen Dixon